Clinical Expert Panel on Monitoring Potential Lung Toxicity of Inhaled Oligonucleotides: Consensus Points and Recommendations
Eric W.F.W. Alton(Imperial College London), Homer A. Boushey(University of California, San Francisco), Joy Cavagnaro(Access to Wholistic and Productive Living Institute), Joel D. Parry(Age UK), Michael R. Hodges(Pfizer (United States)), Jeff Tepper(Integrated Nonclinical Development Solutions (United States)), Holger Garn(Philipps University of Marburg), Graham D. Johnson(Duke University), Francis H. Green(University of Calgary), Paolo Renzi(Université de Montréal), Rosanne Séguin(Pharmaxis (Canada)), Richard J. Martin(University of Bristol), Harald Renz(Philipps University of Marburg), Stephen B. Shrewsbury(Ondine Biopharma (United States)), Robert Murdoch(GlaxoSmithKline (United Kingdom))
Cited by 25
Related Papers
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
|New England Journal of Medicine|2002|3.3k
The microbiome in asthma
|Journal of Allergy and Clinical Immunology|2015|269
Increased regulatory T-cell numbers are associated with farm milk exposure and lower atopic sensitization and asthma in childhood
|Journal of Allergy and Clinical Immunology|2013|205
Epigenetic regulation in murine offspring as a novel mechanism for transmaternal asthma protection induced by microbes
|Journal of Allergy and Clinical Immunology|2011|175
<i>Pseudomonas aeruginosa</i>infection in cystic fibrosis: pathophysiological mechanisms and therapeutic approaches
|Expert Review of Respiratory Medicine|2016|170